ActiveGRANT

DoW Lung Cancer Translational Research Award

Department of DefenseDept. of the Army -- USAMRAA

AI Overview

This DoD funding supports translational lung cancer research converting promising discoveries into clinical applications. Applicants can pursue advanced preclinical studies or pilot clinical trials addressing priority research areas.

This summary is AI-generated from the official solicitation.

Key Details

Agency
Department of Defense
Funding Amount
—
Release Date
May 5, 2026
Due Date
September 2, 2026

Official Description

<p><strong>Summary:</strong> The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.</p><p><br></p><p><strong>Distinctive Features:</strong> This funding mechanism intends to support a broad range of translational studies and allows application submis...
View on official source

Change History

Field UpdatedMay 6, 2026 at 6:47 PM

DoW Lung Cancer Translational Research Award

Minor editorial changes. "DoW" (Department of War or similar designation) was added as a prefix to the title, likely indicating a specific funding source or administering agency, with no changes to program scope or eligibility.

Opportunity AddedMay 5, 2026 at 7:46 PM

Lung Cancer Translational Research Award

New Grants.gov opportunity: Lung Cancer Translational Research Award

Get Alerts for Opportunities Like This

RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.

Start Free Trial